MariMed Inc.
MRMD · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $40,764 | $39,611 | $37,955 | $39,002 |
| % Growth | 2.9% | 4.4% | -2.7% | – |
| Cost of Goods Sold | $24,401 | $23,579 | $22,817 | $26,293 |
| Gross Profit | $16,363 | $16,032 | $15,138 | $12,709 |
| % Margin | 40.1% | 40.5% | 39.9% | 32.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $6,592 | $13,735 | $6,250 | $6,574 |
| SG&A Expenses | $7,713 | $14,496 | $7,148 | $7,807 |
| Sales & Mktg Exp. | $1,121 | $761 | $898 | $1,218 |
| Other Operating Expenses | $7,051 | $395 | $8,841 | $6,307 |
| Operating Expenses | $14,764 | $14,891 | $15,989 | $14,114 |
| Operating Income | $1,599 | $1,141 | -$851 | -$1,405 |
| % Margin | 3.9% | 2.9% | -2.2% | -3.6% |
| Other Income/Exp. Net | -$1,781 | -$1,720 | -$1,738 | -$1,848 |
| Pre-Tax Income | -$182 | -$579 | -$2,589 | -$3,253 |
| Tax Expense | $2,759 | $691 | $2,831 | $4,948 |
| Net Income | -$2,948 | -$1,269 | -$5,452 | -$8,204 |
| % Margin | -7.2% | -3.2% | -14.4% | -21% |
| EPS | -0.01 | -0.003 | -0.014 | -0.022 |
| % Growth | -203% | 76.9% | 33.5% | – |
| EPS Diluted | -0.01 | -0.003 | -0.014 | -0.022 |
| Weighted Avg Shares Out | 392,613 | 389,903 | 382,557 | 379,153 |
| Weighted Avg Shares Out Dil | 392,613 | 389,903 | 382,557 | 379,153 |
| Supplemental Information | – | – | – | – |
| Interest Income | $25 | $25 | $24 | $38 |
| Interest Expense | $1,825 | $1,762 | $1,762 | $1,886 |
| Depreciation & Amortization | $2,789 | $3,083 | $2,756 | $3,044 |
| EBITDA | $4,432 | $4,266 | $1,929 | $1,677 |
| % Margin | 10.9% | 10.8% | 5.1% | 4.3% |